Seres Therapeutics (MCRB) Inventory (2023 - 2024)
Seres Therapeutics (MCRB) posted Inventory of $53.0 million for Q2 2024, up 26.26% sequentially from $42.0 million in Q1 2024, and up 892.45% YoY from $5.3 million in Q3 2023.
Seres Therapeutics (MCRB) Inventory (2023 - 2024) Analysis & Trends
Seres Therapeutics has reported Inventory for 2 years, with the latest figure at $53.0 million in Q2 2024.
- Quarterly Inventory rose 892.45% year-over-year to $53.0 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $53.0 million (up 892.45% YoY) and the FY2023 annual result came in at $29.6 million, changed N/A from the prior year.
- Inventory climbed to $53.0 million in Q2 2024 per MCRB's latest filing, from $42.0 million in the prior quarter.
- Over five years, Inventory peaked at $53.0 million in Q2 2024 and troughed at $5.3 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 97.11 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 142.38 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 128.86 Mn |
| 10 | Seres Therapeutics | 43.82 Mn | 43.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 53.00 Mn |
| Mar 31, 2024 | 41.97 Mn |
| Dec 31, 2023 | 29.65 Mn |
| Sep 30, 2023 | 18.53 Mn |
| Jun 30, 2023 | 5.34 Mn |